View in EDS PDF Full Text

Circulating Tumor DNA as a Prognostic Biomarker for Selecting Participants to Early Phase Clinical Trials.

Saved in:
Bibliographic Details
Title: Circulating Tumor DNA as a Prognostic Biomarker for Selecting Participants to Early Phase Clinical Trials.
Authors: Shaya S; The Christie NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, United Kingdom., Uche-Ikonne O; The Christie NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, United Kingdom., Kilerci B; Cancer Research UK Manchester Institute, Manchester, United Kingdom., Stevenson J; Digital Experimental Cancer Medicine Team, Cancer Research UK Manchester Institute, Manchester, United Kingdom., Greystoke A; Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, United Kingdom.; Newcastle University, Newcastle upon Tyne, United Kingdom., Cook N; The Christie NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, United Kingdom., Thistlethwaite FC; The Christie NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, United Kingdom., Carter L; The Christie NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, United Kingdom., Graham DM; The Christie NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, United Kingdom., Krebs MG; The Christie NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, United Kingdom.
Source: Journal of immunotherapy and precision oncology [J Immunother Precis Oncol] 2025 Aug 25; Vol. 8 (3), pp. 222-232. Date of Electronic Publication: 2025 Aug 25 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Innovative Healthcare Institute Country of Publication: United States NLM ID: 101768397 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-017X (Electronic) Linking ISSN: 2590017X NLM ISO Abbreviation: J Immunother Precis Oncol Subsets: In Process
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40927309
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Circulating Tumor DNA as a Prognostic Biomarker for Selecting Participants to Early Phase Clinical Trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shaya+S%22">Shaya S</searchLink>; The Christie NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Uche-Ikonne+O%22">Uche-Ikonne O</searchLink>; The Christie NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kilerci+B%22">Kilerci B</searchLink>; Cancer Research UK Manchester Institute, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Stevenson+J%22">Stevenson J</searchLink>; Digital Experimental Cancer Medicine Team, Cancer Research UK Manchester Institute, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Greystoke+A%22">Greystoke A</searchLink>; Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, United Kingdom.; Newcastle University, Newcastle upon Tyne, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Cook+N%22">Cook N</searchLink>; The Christie NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Thistlethwaite+FC%22">Thistlethwaite FC</searchLink>; The Christie NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Carter+L%22">Carter L</searchLink>; The Christie NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Graham+DM%22">Graham DM</searchLink>; The Christie NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Krebs+MG%22">Krebs MG</searchLink>; The Christie NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101768397%22">Journal of immunotherapy and precision oncology</searchLink> [J Immunother Precis Oncol] 2025 Aug 25; Vol. 8 (3), pp. 222-232. <i>Date of Electronic Publication: </i>2025 Aug 25 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Innovative+Healthcare+Institute%22">Innovative Healthcare Institute </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101768397 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2590-017X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222590017X%22">2590017X </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Precis Oncol <i>Subsets: </i>In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40927309
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.36401/JIPO-25-11
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 222
    Titles:
      – TitleFull: Circulating Tumor DNA as a Prognostic Biomarker for Selecting Participants to Early Phase Clinical Trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shaya S
      – PersonEntity:
          Name:
            NameFull: Uche-Ikonne O
      – PersonEntity:
          Name:
            NameFull: Kilerci B
      – PersonEntity:
          Name:
            NameFull: Stevenson J
      – PersonEntity:
          Name:
            NameFull: Greystoke A
      – PersonEntity:
          Name:
            NameFull: Cook N
      – PersonEntity:
          Name:
            NameFull: Thistlethwaite FC
      – PersonEntity:
          Name:
            NameFull: Carter L
      – PersonEntity:
          Name:
            NameFull: Graham DM
      – PersonEntity:
          Name:
            NameFull: Krebs MG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 08
              Text: 2025 Aug 25
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2590-017X
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Journal of immunotherapy and precision oncology
              Type: main
ResultId 1